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PURPOSE. To quantify the retinal and choriocapillaris perfusion in different disease stages of
macular telangiectasia type 2 (MacTel) using optical coherence tomography-angiography
(OCT-A).
METHODS. We examined 76 eyes of 76 patients and 24 eyes of 24 age-related controls.
Participants underwent multimodal imaging, including OCT and OCT-A. Patients’ eyes were
divided into three groups considering predefined criteria from funduscopy, OCT, and
fluorescein angiography, thus reflecting the disease severity (‘‘early,’’ ‘‘advanced,’’ and
‘‘neovascular’’). Quantitative analyses of vessel density (VD), skeleton density (SD), and fractal
dimension (FD) were conducted in the superficial and deep retinal plexus and in the
avascular layer. The choriocapillaris was analyzed for mean signal intensity and percentage of
nondetectable perfused choriocapillaris-area (PNPA).
RESULTS. The deep retinal plexus showed a progressive decrease of mean VD, SD, and FD in
the temporal parafovea in all disease stages. In the superficial layer, VD, SD, and FD were
significantly decreased in the temporal parafovea of advanced and neovascular stages, while
these parameters did not differ from controls in early stages. In MacTel, signals of blood flow
were also detectable at the level of the avascular layer and showed a significant increase with
disease progression. The choriocapillaris in MacTel showed a significant increase of mean
PNPA and a decrease of mean signal intensity in comparison to controls. These findings were
consistent in all disease stages.
CONCLUSIONS. Quantitative OCT-A data show a progressive rarefication of the retinal
microvasculature in MacTel. We propose an altered choriocapillaris perfusion as a possibly
early alteration of the disease.
Keywords: macular telangiectasia type 2, MacTel, optical coherence tomography -
angiography, retinal perfusion, choriocapillaris perfusion
Macular telangiectasia (MacTel) type 2 is a bilateral retinaldisease that is characterized by both neurodegenerative
and vascular alterations, that primarily affect the parafoveal
region of the macula.1 The disease may be diagnosed and
graded into five stages according to the system proposed by
Gass and Blodi.2 However, this classification is not necessarily
consecutive and only considers morphological findings from
funduscopy and fundus fluorescein angiography (FFA). Recent-
ly, novel imaging modalities such as optical coherence
tomography (OCT) and OCT-angiography (OCT-A) are gaining
in importance for making the diagnosis and assessing the
disease severity.3 In this context, the ellipsoid zone (EZ) and its
integrity are of particular interest: eyes with MacTel may show a
loss of the EZ that usually increases with disease progression
and has been shown to be associated with decreased retinal
sensitivity.3 The loss of the EZ was thus proposed to serve as a
marker of disease severity.4,5
OCT-A is a novel, noninvasive imaging method that shows
motion contrast in the retina, and thus can provide detailed
three-dimensional images of the perfused microvasculature in
different retinal layers and in the choroid.6–11 Previous OCT-A
studies of the retinal vasculature in MacTel have observed a
decrease of capillary density, dilated and telangiectatic vessels,
and the presence of abnormal anastomoses in the outer
retina.12–14 However, different quantifiable vascular parameters
and their changes with disease progression have not yet been
systematically investigated, and OCT-A studies on the perfusion
of the choriocapillaris remain outstanding.
In this study, we quantify vascular changes in the superficial
and deep retinal plexus, in the avascular layer, and in the
choriocapillaris of eyes with different disease stages of MacTel
using OCT-A.
METHODS
In this cross-sectional analysis, consecutive participants with a
confirmed diagnosis of MacTel were recruited from the Natural
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History and Observation Study (NHOS) from a single center
cohort at the Department of Ophthalmology, University
Hospital of Bonn, Germany. Protocol details of the study have
been published previously.15 The diagnosis of MacTel type 2
was based on characteristic findings in funduscopy, spectral
domain optical coherence tomography (SD-OCT), macular
pigment optical density (MPOD), and fundus fluorescein
angiography (FFA).1 Controls were age-matched healthy
probands without any evidence of retinal diseases and clear
media. Patients and controls underwent a full clinical
examination, including best-corrected visual acuity (BCVA)
testing, dilated funduscopy, SD-OCT (volume scans of 158 3
108, high resolution mode, 97 scans [Spectralis; Heidelberg
Engineering, Heidelberg, Germany]) and OCT-angiography
(100k A-scans/second at 1060 nm, macular scans of 3 3 3
mm formed by 312 horizontal A-scans, with four repeated
scans in each fixed location, one volume scan per eye; Zeiss
PLEX Elite 9000; Carl Zeiss Meditec, Dublin, CA, USA). OCT-A
images were generated using an optical microangiography
complex (OMAGc) algorithm.
Inclusion criteria were a complete imaging data set and
sufficient imaging quality. The right eye was selected as study
eye, unless inclusion criteria were not met. In these cases (n¼
4), the left eye was selected as study eye.
The study was approved by the local ethics committee of
the Friedrich-Wilhelms-University of Bonn, Bonn, Germany,
and was conducted in accordance to the tenets of the
Declaration of Helsinki. All participants provided informed
consent.
Eyes with MacTel were classified according to their disease
severity into three groups (‘‘early,’’ ‘‘advanced,’’ and ‘‘neovas-
cular’’). Early disease was defined as no visible disruption of
the ellipsoid zone on OCT B-scans and no visible pigment
changes on funduscopy, but typical findings in FFA, MPOD,
and/or in the fellow eye. Eyes with any loss of the EZ on OCT
and with or without pigment changes on funduscopy were
defined as ‘‘advanced,’’ and eyes with secondary neovascular
membranes were defined as ‘‘neovascular.’’
Image Processing and Analysis
For segmentation of the OCT-A images into superficial, deep,
avascular, and choriocapillaris layer, a semiautomated segmen-
tation algorithm was applied, and subsequent manual adjust-
ment of segmentation lines considering individual layer
variation and shift in the context of the disease16 was
conducted. Layer segmentation was based on relevant anatom-
ic structures: the superficial layer was defined reaching from
the inner boundary of the retinal nerve fiber layer to the outer
boundary of the inner plexiform layer (IPL), the deep layer
reaching from the outer boundary of IPL to the outer boundary
of the outer plexiform layer (OPL), and the avascular layer
reaching from the outer boundary of OPL to the outer
boundary of the RPE. The latter layer usually does not contain
vascular networks in healthy subjects. The choriocapillaris
(CC) layer was defined as a slab reaching from 10 to 40 lm
below the RPE-fit segmentation. The definitions of the
superficial and deep retinal layer correspond to the definition
of the superficial and deep retinal plexuses in the current OCT-
A nomenclature.17 OCT-A images were generated using the
maximum projection algorithm of the instrument software of
each particular slab within the artifact-corrected volume.18,19
Image Postprocessing and Quantitative Analysis
Images of all layers were exported and analyzed using the FIJI
software (an expanded version of ImageJ, version 1.51a,
available at fiji.sc, provided in the public domain by the
National Institute of Health, Bethesda, MD, USA).20,21 The
superficial and the deep plexus were binarized using the
maximum intensity of the foveolar avascular zone as a
threshold determined by two masked readers (ST and CM).
After binarization, images were skeletonized. Vessel density
(VD), skeleton density (SD), and vessel diameter index (VDI)
were calculated from the resulting images using the FIJI
software as previously described.22 Fractal dimension (FD) was
calculated using the box counting method with FracLac, a
plug-in for ImageJ (Karperien A, FracLac for ImageJ, available at
http://rsb.info.nih.gov/ij/plugins/fraclac/FLHelp/Introduction.
htm).23 In MacTel, pathologic alterations usually arise and are
most pronounced in the temporal parafovea, predisposing this
area to study both early and progressed disease-related
changes. In order to determine the position of the temporal
parafovea, a customized template following the subfields of the
ETDRS-grid (as used in the Early Treatment Diabetic Retinop-
athy Study)24,25 was centered on the foveolar avascular zone.
Quantitative analyses of the superficial and deep retinal plexus
were primarily conducted in the temporal parafoveal subfield
(Fig. 1, indicated in red). The size of this standardized template
was customized (Fig. 1: size of the inner, yellow circle: 0.9 mm
diameter, size of the outer, red circle: 2.4 mm diameter) in
order to fit into the borders of the image and include the area
FIGURE 1. Exemplary illustration of the superficial, deep and avascular
layer in patient and control eyes (images are postprocessed and
binarized). The red template indicates the temporal parafoveal area,
the blue templates indicate the nasal, superior and inferior subfields for
quantitative measurements. With disease progression, patient eyes
show an increase of intervascular spaces and rarefication as well as a
thickening of small capillaries, resulting in an irregular shape of the
foveolar avascular zone. In advanced disease stages, flow signals can be
observed at the level of the avascular layer.
Vascular Perfusion in Different Stages of MacTel 2 IOVS j August 2019 j Vol. 60 j No. 10 j 3557
Downloaded from iovs.arvojournals.org on 09/23/2019
of interest. In cases, where the FAZ was irregularly distorted
(e.g., in eyes with progressed disease stages), the center of the
FAZ was determined following neighboring vessels of the
nasal, superior and inferior parafovea. In a secondary analysis,
quantitative measures were also conducted within the nasal,
inferior and superior parafoveal subfields (Fig. 1, indicated in
blue). For binarization of the avascular layer, the borders of the
FAZ were projected within the avascular layer and thresholding
was conducted using the maximum intensity that was
determined within this area (see Supplementary Fig. S1, the
projection of the FAZ is indicated with a yellow-dotted
outline). The avascular layer usually does not show signals of
blood flow in healthy subjects. Vessel density (VD) was
subsequently calculated from the resulting complete image (3
3 3 mm) using the FIJI software as previously described.20,22
The CC-slab was analyzed for mean signal intensity, kurtosis
and percentage of nondetectable perfused CC-area (PNPA) as
previously described.26,27 In brief, images were binarized using
the Phansalkar method (radius of 50 pixels). Subsequently, the
‘‘Analyze particles’’ command of FIJI enabled to count and
assess the size of all areas containing an absence of flow
information (‘‘flow voids’’) as a percentage of the nondetect-
able perfused area (PNPA).28 Kurtosis is a statistical parameter
that can be used in order to describe the signal intensity
distribution of a grey-level image.29,30 Its application for
characterizing the frequency of intensity values in CC-sections
of OCT-A images has previously been described.27 In neovas-
cular eyes, the exact localization and extension of neovascular
membranes was determined, and the respective area was
excluded from the quantitative CC-analyses.
Statistical Analysis
Statistical analysis was performed using graphing software
(GraphPad Prism, version 7.05; GraphPad Software, San Diego,
CA, USA). Continuous variables were described by using the
mean 6 standard deviation and categorical variables were
analyzed using frequency tables. For intergroup comparisons 1-
way ANOVA with Bonferroni correction for multiple testing
was computed, unless otherwise indicated. Intraclass correla-
tion was used in order to assess interreader reliability for the
determination of the maximum intensity within the FAZ. A P
value <0.05 was accepted as statistically significant.
RESULTS
Data of 76 eyes of 76 patients (mean age of 62.3 years 6 SD
6.1; range, 49–78) and 24 eyes of 24 age-matched controls
(mean age of 61.5 years 6 SD 5.9; range, 46–75) were included
in this analysis. We graded 18 eyes as early, 45 as advanced and
13 as neovascular.
With disease progression, eyes with MacTel showed an
increase of intervascular spaces and rarefication of vessels as
well as a thickening of parafoveal capillaries, resulting in an
irregular shape of the foveolar avascular zone. These alter-
ations were present both in the superficial and deep retinal
plexus and were most pronounced in the temporal parafovea.
In eyes with advanced disease stages, flow signals were also
observed at the level of the avascular layer. Examples of the
superficial, deep and avascular layer in patient and control eyes
are shown in Figure 1.
Quantitative assessments in the temporal sector of the
superficial plexus revealed a significant decrease of mean VD,
SD, and FD in eyes with advanced and neovascular disease
stages, respectively (in comparison to controls all P < 0.001;
Fig. 2). In early stages, however, these parameters did not differ
from controls.
In the temporal sector of the deep plexus, all groups showed
a significant decrease of mean VD, SD, and FD (all P < 0.001) in
comparison to controls, that further decreased with disease
progression. Quantitative data (mean values 6 standard
deviations) for measurements within the temporal parafovea
are shown in Figure 2 and listed in the Table of the supplement.
FIGURE 2. Quantitative measures (single values, mean values and
standard deviations) of vessel density (A), skeleton density (B), and
fractal dimension (C) in the superficial and deep plexus of MacTel and
control eyes. In the deep plexus, all parameters show a decrease in
patients. In the superficial plexus, eyes with advanced and neovascular
stages show a significant decrease of all parameters, while eyes with
early stages do not differ from controls. Controls: n ¼ 24; patients:
early: n ¼ 18; progressed: n ¼ 45; neovascular: n ¼ 13. NS, no
significant difference. ***P < 0.001. ****P < 0.0001.
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In a comparative analysis quantitative measures within the
nasal, superior, inferior, and temporal parafoveal sectors were
compared between patients and controls. In addition to the
above reported changes within the temporal sector, significant
differences between patients and controls were only found for
the nasal sector of the deep plexus in eyes with advanced and
neovascular stages, respectively. Here, we found a significant
decrease of VD, SD, and FD in comparison to control eyes (all P
< 0.01; Supplementary Figure S2).
At the level of the avascular layer, signals of blood flow were
only observed in eyes with advanced disease stages (Fig. 1). A
quantitative analysis of these changes (VD only) revealed a
significant increase of mean VD in eyes with advanced and
neovascular stages, respectively (for both P < 0.001, see
Supplementary Table S1). Though in some eyes with early
disease stages single signals of blood flow were detectable
within the avascular layer, the difference to control eyes,
where the avascular layer showed no signal at all, was not
significant.
The quantitative analysis of the CC revealed a significantly
reduced mean signal intensity as well as a reduced kurtosis of
signal intensity distribution in all groups of MacTel eyes (all P <
0.001), indicating a more heterogenous OCT-A signal with a
wider distribution (Table; Fig. 3; Supplementary Fig. S3).
Furthermore, there were more choriocapillaris perfusion flow-
voids (indicated by a significant increase of mean PNPA; all P <
0.001; Fig. 3C) in MacTel eyes compared to controls. Notably,
among our patients, we found no significant differences
between eyes of early, advanced and neovascular stages,
respectively (Figs. 3B–D). Quantitative data of CC perfusion
parameters are shown in the Table. Interestingly, in eyes with
neovascular stages, a focal increase of flow voids was observed
surrounding neovascular membranes (Fig. 4).
Interreader agreement was high for the determination of
thresholds for binarization of the superficial, deep, and
TABLE. Quantitative Data (mean values 6 SD) of Choriocapillaris Perfusion Parameters
PNPA [%] Kurtosis Signal Intensity
Mean 6 SD P Value* Mean 6 SD P Value* Mean 6 SD P Value*
Controls 17.7 6 3.8 NA 1.77 6 0.7 NA 209.8 6 11.1 NA
Early 30.1 6 3.5 <0.001 1.17 6 0.6 <0.0001 177.3 6 15.2 <0.001
Advanced 32.1 6 3.4 <0.001 1.40 6 0.3 <0.0001 173.1 6 10.7 <0.0001
Neovascular 34.3 6 4.1 <0.0001 1.43 6 0.4 <0.0001 166.5 6 15.3 <0.0001
Parameters include the percentage of nondetectable perfused area (PNPA), mean signal intensity, and kurtosis of signal intensity distribution) in
patients and controls.
* The listed P values describe the significances of differences between each disease stage (early, advanced, neovascular) and controls (1-way
ANOVA test with Bonferroni correction for multiple testing).
FIGURE 3. (A) Exemplary illustration of the choriocapillaris layer in controls and patients. Patients show an overall increase of flow voids that seems
to be present in all disease stages. In the neovascular eye, the neovascular membrane is marked as white area, that was excluded from the
quantitative analysis. (B–D) Quantification of mean signal intensity (B), percentage of nondetectable perfused area (PNPA; [C]), and kurtosis of
signal intensity distribution (D) in the choriocapillaris layer of patients and controls. The mean PNPA is significantly increased, while the mean
signal intensity and kurtosis are significantly decreased in all disease stages in comparison to controls (***P < 0.001, ****P < 0.0001).
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avascular retinal layers (intraclass correlation coefficients and
confidence intervals: superficial layer: 0.84; 0.80–0.94; deep
layer: 0.87; 0.77–0.9; and avascular layer: 0.81; 0.79–0.9).
DISCUSSION
Although MacTel was lately considered to be possibly a
primarily neurodegenerative disease, it is also characterized
by its vascular alterations. While characteristic vascular
changes in funduscopy and fluorescein angiography may help
to make the diagnosis, OCT-A allows to differentiate, allocate,
and quantify vascular changes within different retinal layers
and the choroid.6–11 Previous studies showed a decrease of
mean capillary density and rarefication in both superficial and
deep retinal plexus in eyes with MacTel.12,13,31 It was
suggested that vascular changes might first arise in the deep
layer, and only later in the disease course extend to the
superficial layer and outer retina. However, so far, neither
longitudinal data nor a systematic analysis of eyes with
different stages was available supporting this hypothesis. In
this study, we showed a progressive rarefication of vessels in
the temporal parafovea of the deep retinal plexus indicated by
a significant decrease of vessel and skeleton density in all
disease stages. In the superficial plexus, however, a decrease of
vessel and skeleton density within the temporal parafovea was
only detectable in eyes with advanced and neovascular stages,
while early stages did not differ from controls. This finding
supports that earliest vascular changes arise in the deep
plexus, while visible alterations in the superficial plexus may
be considered a sign of more advanced disease. While in the
superficial plexus changes were limited to the temporal
parafovea, a decrease of vessel and skeleton density was also
observed within the nasal parafovea of the deep plexus of eyes
with advanced and neovascular stages. This may be explained
by the known extension of morphological changes to the nasal
parafovea with disease progression,32–34 and further supports
the hypothesis of changes to arise in the deep plexus first.
In line with recent findings,12,35 we observed the presence
of pathologic vascular structures in the avascular layer of eyes
with advanced and neovascular disease stages, but not in early
stages. Though different studies proposed a descent of vascular
changes to the outer retina,12,35,36 segmentation of retinal
layers in eyes with advanced disease stages may be challenging,
and a collapse of retinal layers due to increasing atrophy may at
least in part be responsible for the observed phenomenon.
While alterations of the retinal vasculature have long been
known, the role of vascular changes in the choriocapillaris and
choroid in MacTel is still obscure. The involvement of
choroidal vessels in the context of secondary NVs in MacTel
has been controversially discussed.36–39 In a recent qualitative
analysis, we showed an increase of flow voids and irregular
appearance of the choriocapillaris in eyes with advanced (but
non-proliferative) disease stages.36 In this study, we quantified
these changes and found an overall reduced and more irregular
perfusion of the choriocapillaris indicated by a significant
increase of flow voids and reduced kurtosis of signal intensity
distribution. Notably, these findings were already observed in
early disease stages, indicating an earlier affection of the
choroid than previously expected. Though changes of CC
perfusion seemed to be most pronounced within the central
parafoveal region to which morphologic alterations are usually
limited in MacTel, they also seemed to extend beyond this area,
thus implying an overall broader affection of the choriocapil-
laris. Interestingly, in eyes with neovascular disease stages, we
observed a pronounced focal increase of flow voids surround-
ing neovascular membranes. Though a hypoperfusion of the
choriocapillaris may be considered a new and intriguing
finding in MacTel, these findings must be interpreted with
caution. Superimposing structures, and especially dense
pigment plaques and prominent vessels, may cause shadowing
artefacts and may thus enhance the impression of an altered
structure of the choriocapillaris. Furthermore, in general,
imaging of the choriocapillaris in vivo is still challenging and
movement artefacts and speckle noise may influence image
quality. Nevertheless, a hypoperfusion and possibly resulting
hypoxia of the choriocapillaris might represent a conceivable
trigger factor for a shift of retinal vessels to the outer retina,
and the development and growth of neovascularizations in
eyes with MacTel.
Study Limitations
This study was conducted in a cross-sectional manner. Future
collection of longitudinal data is needed in order to verify our
results.
Furthermore, our data were not corrected for axial length
variations and resulting retinal magnification. Though, refrac-
tion errors were overall low in our proband cohort and did not
differ between patients and controls (patients: median
refraction error:þ0.75 diopters (range,3.5 toþ3.75 diopters)
and controls: median: þ0.5 diopters (range, 4.0 to þ3.5
diopters), axial length variations might have influenced our
results.
The occurrence of atrophy and NV-associated changes
resulting in an altered retinal architecture complicates the
segmentation of OCT images and causes imaging artefacts that
may influence the test results in spite of careful review and
manual correction of segmentation. Furthermore, shadowing
artefacts of large vessels and pigment plaques may impede the
evaluation of subjacent structures (especially in the avascular
and choriocapillaris layer), though an algorithm subtracting
artefacts caused by superimposing structures was applied, and
FIGURE 4. Exemplary illustration of choriocapillaris sections of eyes with neovascular disease stages. Neovascular membranes are marked as white
areas. Note the increase of flow voids in the perimembranous zone, indicated with white arrowheads.
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areas with dense structures (e.g., neovascular membranes)
were excluded from the quantitative analysis of the CC layer.
CONCLUSIONS
We provide quantitative OCT-A data showing a rarefication of
the microvasculature in the superficial and deep retinal plexus,
that increases with disease progression in eyes with MacTel.
We propose an altered choriocapillaris perfusion as a possibly
early alteration in MacTel.
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